(VRLA) Verallia - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0013447729
Stock: Glass, Bottles, Jars, Packaging
Total Rating 40
Risk 81
Buy Signal 0.33
Dividends
| Dividend Yield | 6.07% |
| Yield on Cost 5y | 7.33% |
| Yield CAGR 5y | 15.66% |
| Payout Consistency | 96.4% |
| Payout Ratio | 3.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 27.6% |
| Relative Tail Risk | -10.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.70 |
| Alpha | -17.01 |
| Character TTM | |
|---|---|
| Beta | -0.003 |
| Beta Downside | -0.164 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.48% |
| CAGR/Max DD | -0.21 |
Description: VRLA Verallia January 12, 2026
Verallia SA (PA:VRLA) is a global manufacturer of glass packaging, supplying bottles for wines, spirits, beers, soft drinks and oils, as well as jars for a wide range of food products such as baby food, dairy, sauces and seafood. Founded in 1827 and headquartered in Courbevoie, France, the company also offers value-added services like design, logistics and recycling solutions.
Key performance indicators from the most recent fiscal year show revenue of €3.2 billion, an adjusted EBITDA margin of roughly 12 %, and a recycling rate of glass containers exceeding 70 %, reflecting strong demand for sustainable packaging. The glass sector is currently driven by rising raw-material costs (soda ash and silica), tightening environmental regulations that favor recyclable materials, and a shift toward premium beverage formats that command higher glass usage.
For a deeper quantitative dive into Verallia’s valuation metrics and peer comparison, you might find the analysis on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 462.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -0.80 > 1.0 |
| NWC/Revenue: 0.01% < 20% (prev -0.06%; Δ 0.08% < -1%) |
| CFO/TA 0.25 > 3% & CFO 1.10b > Net Income 462.5m |
| Net Debt (1.95b) to EBITDA (1.56b): 1.25 < 3 |
| Current Ratio: 1.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (118.2m) vs 12m ago 0.82% < -2% |
| Gross Margin: 19.45% > 18% (prev 0.25%; Δ 1920 % > 0.5%) |
| Asset Turnover: 154.7% > 50% (prev 123.0%; Δ 31.68% > 0%) |
| Interest Coverage Ratio: 4.21 > 6 (EBITDA TTM 1.56b / Interest Expense TTM 211.1m) |
Altman Z'' 2.36
| A: 0.00 (Total Current Assets 1.43b - Total Current Liabilities 1.42b) / Total Assets 4.51b |
| B: 0.17 (Retained Earnings 764.1m / Total Assets 4.51b) |
| C: 0.20 (EBIT TTM 889.0m / Avg Total Assets 4.49b) |
| D: 0.45 (Book Value of Equity 1.62b / Total Liabilities 3.59b) |
| Altman-Z'' Score: 2.36 = BBB |
Beneish M -3.10
| DSRI: 0.59 (Receivables 230.5m/311.5m, Revenue 6.94b/5.49b) |
| GMI: 1.28 (GM 19.45% / 24.98%) |
| AQI: 0.94 (AQ_t 0.26 / AQ_t-1 0.27) |
| SGI: 1.26 (Revenue 6.94b / 5.49b) |
| TATA: -0.14 (NI 462.5m - CFO 1.10b) / TA 4.51b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of VRLA shares?
As of February 09, 2026, the stock is trading at EUR 23.56 with a total of 41,271 shares traded.
Over the past week, the price has changed by +6.99%, over one month by +2.70%, over three months by +4.80% and over the past year by -12.87%.
Over the past week, the price has changed by +6.99%, over one month by +2.70%, over three months by +4.80% and over the past year by -12.87%.
Is VRLA a buy, sell or hold?
Verallia has no consensus analysts rating.
What are the forecasts/targets for the VRLA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.3 | 15.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 24.8 | 5.3% |
VRLA Fundamental Data Overview February 03, 2026
Market Cap USD = 3.08b (2.60b EUR * 1.1827 EUR.USD)
P/E Trailing = 14.6358
P/E Forward = 6.5274
P/S = 0.7627
P/B = 3.043
Revenue TTM = 6.94b EUR
EBIT TTM = 889.0m EUR
EBITDA TTM = 1.56b EUR
Long Term Debt = 1.88b EUR (from longTermDebt, last quarter)
Short Term Debt = 398.9m EUR (from shortTermDebt, last quarter)
Debt = 2.32b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.95b EUR (from netDebt column, last quarter)
Enterprise Value = 4.85b EUR (2.60b + Debt 2.32b - CCE 74.6m)
Interest Coverage Ratio = 4.21 (Ebit TTM 889.0m / Interest Expense TTM 211.1m)
EV/FCF = 9.24x (Enterprise Value 4.85b / FCF TTM 525.3m)
FCF Yield = 10.83% (FCF TTM 525.3m / Enterprise Value 4.85b)
FCF Margin = 7.57% (FCF TTM 525.3m / Revenue TTM 6.94b)
Net Margin = 6.66% (Net Income TTM 462.5m / Revenue TTM 6.94b)
Gross Margin = 19.45% ((Revenue TTM 6.94b - Cost of Revenue TTM 5.59b) / Revenue TTM)
Gross Margin QoQ = 17.34% (prev 17.30%)
Tobins Q-Ratio = 1.08 (Enterprise Value 4.85b / Total Assets 4.51b)
Interest Expense / Debt = 2.29% (Interest Expense 53.2m / Debt 2.32b)
Taxrate = 23.09% (20.3m / 87.9m)
NOPAT = 683.7m (EBIT 889.0m * (1 - 23.09%))
Current Ratio = 1.00 (Total Current Assets 1.43b / Total Current Liabilities 1.42b)
Debt / Equity = 2.73 (Debt 2.32b / totalStockholderEquity, last quarter 850.3m)
Debt / EBITDA = 1.25 (Net Debt 1.95b / EBITDA 1.56b)
Debt / FCF = 3.72 (Net Debt 1.95b / FCF TTM 525.3m)
Total Stockholder Equity = 904.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.31% (Net Income 462.5m / Total Assets 4.51b)
RoE = 51.14% (Net Income TTM 462.5m / Total Stockholder Equity 904.4m)
RoCE = 31.97% (EBIT 889.0m / Capital Employed (Equity 904.4m + L.T.Debt 1.88b))
RoIC = 23.09% (NOPAT 683.7m / Invested Capital 2.96b)
WACC = 3.95% (E(2.60b)/V(4.93b) * Re(5.91%) + D(2.32b)/V(4.93b) * Rd(2.29%) * (1-Tc(0.23)))
Discount Rate = 5.91% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.44%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈537.7m ; Y1≈663.2m ; Y5≈1.13b
Fair Price DCF = 262.6 (EV 32.89b - Net Debt 1.95b = Equity 30.94b / Shares 117.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -29.38 | EPS CAGR: -41.31% | SUE: 0.0 | # QB: 0
Revenue Correlation: 79.92 | Revenue CAGR: 14.86% | SUE: 2.19 | # QB: 1
EPS next Year (2026-12-31): EPS=2.26 | Chg30d=-0.048 | Revisions Net=-2 | Growth EPS=+23.6% | Growth Revenue=+1.5%
P/E Trailing = 14.6358
P/E Forward = 6.5274
P/S = 0.7627
P/B = 3.043
Revenue TTM = 6.94b EUR
EBIT TTM = 889.0m EUR
EBITDA TTM = 1.56b EUR
Long Term Debt = 1.88b EUR (from longTermDebt, last quarter)
Short Term Debt = 398.9m EUR (from shortTermDebt, last quarter)
Debt = 2.32b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.95b EUR (from netDebt column, last quarter)
Enterprise Value = 4.85b EUR (2.60b + Debt 2.32b - CCE 74.6m)
Interest Coverage Ratio = 4.21 (Ebit TTM 889.0m / Interest Expense TTM 211.1m)
EV/FCF = 9.24x (Enterprise Value 4.85b / FCF TTM 525.3m)
FCF Yield = 10.83% (FCF TTM 525.3m / Enterprise Value 4.85b)
FCF Margin = 7.57% (FCF TTM 525.3m / Revenue TTM 6.94b)
Net Margin = 6.66% (Net Income TTM 462.5m / Revenue TTM 6.94b)
Gross Margin = 19.45% ((Revenue TTM 6.94b - Cost of Revenue TTM 5.59b) / Revenue TTM)
Gross Margin QoQ = 17.34% (prev 17.30%)
Tobins Q-Ratio = 1.08 (Enterprise Value 4.85b / Total Assets 4.51b)
Interest Expense / Debt = 2.29% (Interest Expense 53.2m / Debt 2.32b)
Taxrate = 23.09% (20.3m / 87.9m)
NOPAT = 683.7m (EBIT 889.0m * (1 - 23.09%))
Current Ratio = 1.00 (Total Current Assets 1.43b / Total Current Liabilities 1.42b)
Debt / Equity = 2.73 (Debt 2.32b / totalStockholderEquity, last quarter 850.3m)
Debt / EBITDA = 1.25 (Net Debt 1.95b / EBITDA 1.56b)
Debt / FCF = 3.72 (Net Debt 1.95b / FCF TTM 525.3m)
Total Stockholder Equity = 904.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.31% (Net Income 462.5m / Total Assets 4.51b)
RoE = 51.14% (Net Income TTM 462.5m / Total Stockholder Equity 904.4m)
RoCE = 31.97% (EBIT 889.0m / Capital Employed (Equity 904.4m + L.T.Debt 1.88b))
RoIC = 23.09% (NOPAT 683.7m / Invested Capital 2.96b)
WACC = 3.95% (E(2.60b)/V(4.93b) * Re(5.91%) + D(2.32b)/V(4.93b) * Rd(2.29%) * (1-Tc(0.23)))
Discount Rate = 5.91% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.44%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈537.7m ; Y1≈663.2m ; Y5≈1.13b
Fair Price DCF = 262.6 (EV 32.89b - Net Debt 1.95b = Equity 30.94b / Shares 117.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -29.38 | EPS CAGR: -41.31% | SUE: 0.0 | # QB: 0
Revenue Correlation: 79.92 | Revenue CAGR: 14.86% | SUE: 2.19 | # QB: 1
EPS next Year (2026-12-31): EPS=2.26 | Chg30d=-0.048 | Revisions Net=-2 | Growth EPS=+23.6% | Growth Revenue=+1.5%